SOME PROMISSING DRUGS created by structure-based design strategies are in clinical trials. Among them are inhibitors of an enzyme produced by the AIDS-causing virus, HIV (Abbott's version appears as spheres in the top photograph.) Another example is an inhibitor of the enzyme thrombin, designed to reduce blood clotting (bottom photograph).